GenScript Biotech climbs 6%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

GenScript Biotech (1548.HK) climbed more than 6% in Hong Kong trading to HK$31.46.

The stock is down 9.73% over the past five sessions and up 152.50% year to date. It sits 203.67% above its 52-week low of HK$10.36.

The Hang Seng Index is down 3.92% over the past five sessions and down 8.85% year to date.

The company has entered into a strategic partnership with Tencent Health on AI-driven drug discovery and development. The collaboration integrates Tencent's AI, high-performance computing and cloud capabilities with GenScript's life sciences experimental systems to advance a research model combining computational prediction with wet lab validation. GenScript will serve as a key wet lab validation partner for Tencent Health's BioNexus platform.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.